Neos Therapeutics, Inc. Financial Statements 2011-2024 | NEOS

Annual Financial Statements Neos Therapeutics, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	80.6 M	67.8 M	275 M	95.5 M	103 M	-	-	-	-
Shares	-	49.7 M	32.3 M	24.8 M	16.1 M	7.58 M	-	-	-	-
Net Income	-	-16.9 M	-51.7 M	-66.2 M	-83.3 M	-30.8 M	-20.8 M	-19 M	-	-
Revenue	-	64.6 M	50 M	25 M	9.15 M	3.79 M	758 K	1.04 M	-	-
EBITDA	-	-6.22 M	-40 M	-54 M	-73.1 M	-23.3 M	-15.8 M	-14.9 M	-	-
Operating Expenses	-	49.9 M	66.6 M	69.6 M	74.1 M	24.8 M	15.9 M	15.6 M	-	-
General and Administrative Expenses	-	13.2 M	13.9 M	13.8 M	12.6 M	7.47 M	-	5.47 M	-	-

All numbers in USD currency